COMMUNIQUÉS West-GlobeNewswire

AC Immune to Present at the Jefferies 2025 London Healthcare Conference
11/11/2025
AC Immune to Present at the Jefferies 2025 London Healthcare Conference Lausanne, Switzerland, November 11, 2025 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision [...]
Ernexa Therapeutics to Present at Oxford Global’s Cell 2025
11/11/2025
Sanjeev Luther, President and CEO to give an oral presentation and participate in a moderated panel discussion CAMBRIDGE, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry [...]
NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
11/11/2025
Conference call will be held today, Tuesday, November 11 at 9:00 am ET CARMEL, Ind., Nov. 11, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company [...]
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value
11/11/2025
Confirms Receipt of Unsolicited Indication of Interest and Director Nominations from Lynx1 Master Fund LP No Stockholder Action Required at This Time BURLINGTON, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Neuphoria [...]
Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement
11/11/2025
REDWOOD CITY, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today [...]
New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans
11/11/2025
Prospective study data and retrospective registry data were analyzed in the manuscripts recently published by the Journal of Cataract and Refractive Surgery, Journal of Glaucoma and Clinical Ophthalmology MENLO PARK, [...]
Solésence Reports Third Quarter 2025 Financial Results
11/11/2025
Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in [...]
Flower by Edie Parker Announces Exclusive Partnership with Verano to Launch Cannabis Line in Florida with Campaign Starring Miami Native and Grammy-Nominated Rapper JT
11/11/2025
NEW YORK, NY, & CHICAGO, IL, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Edie Parker (the “Company”), a leading female founded, female operated lifestyle brand merging the worlds of fashion and cannabis, today announced an [...]
Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference
11/11/2025
FRIENDSWOOD, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management [...]
Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences
11/11/2025
WALTHAM, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
CorVel Earns Spot on TIME’s America’s Growth Leaders 2026 List — the Only Company in Its Industry Recognized
11/11/2025
Recognition reflects CorVel’s sustained growth, financial strength, and market performance FORT WORTH, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Today, CorVel Corporation (NASDAQ: CRVL), a national provider of risk [...]
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights
11/11/2025
R evenue increase d 29% to $ 13.5 million in Q3 2025 as compared with Q 3 202 4 Operating income totaled $ 1. 3 million and Adjusted EBITDA rose approximately 80% to $ 2.0 million in Q3 2025, as compared with Q3 2024 [...]
Palvella Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
11/11/2025
Palvella’s recently expanded rare disease pipeline now comprises QTORIN™-derived product candidates advancing in four serious, rare skin diseases that currently have no FDA-approved therapies Top-line results for fully [...]
Oncotelic Therapeutics and Sapu Bioscience Announce Publication on Sub-15 nm Nanoparticles in International Journal of Molecular Sciences
11/11/2025
Breakthrough Review Defines the Next Frontier in Precision Nanomedicine Agoura Hills, CA, and San Diego, CA, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics Inc. (OTLC) and JV partner Sapu Bioscience today [...]
Prime Medicine to Present at Jefferies Global Healthcare Conference
11/11/2025
CAMBRIDGE, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced [...]
March Biosciences Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for MB-105 in Relapsed/Refractory CD5-Positive T-Cell Lymphoma
11/11/2025
HOUSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), a clinical stage biotechnology company developing cell therapies for hard-to-treat cancers, today announced that the U.S. Food and Drug [...]
Daré Bioscience Highlights Commercial Launch Readiness for DARE to PLAY™ Sildenafil Cream; November 17th Webinar to Feature Leading Clinicians Discussing Clinical Data and Potential Impact in Women’s Sexual Health
11/11/2025
Event to Explore What Makes DARE to PLAY™ a First-of-Its-Kind Topical Sildenafil Cream for Women, Review Supporting Clinical Data, and Discuss 503B Pathway to Commercial Availability, Expected Before Year-End SAN DIEGO [...]
Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine
11/11/2025
Turn’s Topical IL36/IL31 Inhibitor Named Alongside Other Phase 2 & 3 Candidates from Amgen, Sanofi, Leo Pharma, Apogee Therapeutics, and Nektar Therapeutics LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Turn [...]
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
11/11/2025
BRISBANE, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, [...]

Pages